Author

Monika Patel

Central Drug Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

Prem Narayan YadaviD· 2 shared Aditya SinghiD· 1 shared Aishi Satapathy· 1 shared Ashish KumariD· 1 shared H.N. Yadav· 1 shared Hamim ZafariD· 1 shared Mriganka De Sarkar· 1 shared Raashidha Farhath· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

Prem Narayan YadavORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Myeloid Gi signaling acts as a weight-independent immunometabolic switch controlling systemic insulin sensitivity

Seema Kuldeep, H.N. Yadav, Seema Riyaz, Soumita Bhaumik, Shruti Agarwal, Aishi Satapathy, Simran Singh, Ashish Kumar, Sudipta Paul, Monika Patel, Mriganka De Sarkar, Raashidha Farhath, Sonal Amit, Rashmi Parihar, Hamim Zafar, , Sai Prasad Pydi

This paper identifies myeloid Gi signaling as a weight-independent immunometabolic switch that regulates systemic insulin sensitivity through opposing cytokine programs.

bioRxiv · Mar 31, 2026 · PreprintPhysiology

CXCL10/CXCR3 Signaling Induces Neural Senescence and Cognitive Impairments

Monika Patel, Sakesh Kumar, Aditya Singh, Prem Narayan Yadav

This study shows that CXCL10/CXCR3 signaling promotes neural senescence and cognitive impairments in mice, with effects blocked by a CXCR3 antagonist.

bioRxiv · Oct 16, 2024 · PreprintNeuroscience